Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire5 February 2026New Published Case Series Explores Umbilical Cord Tissue Allografts in Plantar Fascia Care
PENSACOLA, Fla., Feb. 4, 2026 /PRNewswire/ — Regenative Labs, in collaboration with Babak Baravarian, DPM, Director of Foot & Ankle…
Read More » -
Cision PR Newswire5 February 2026
GLP China Holdings Limited TENDER OFFER TO PURCHASE FOR CASH ANY AND ALL OF ITS U.S.$700,000,000 2.95 PER CENT. NOTES DUE 2026
(普洛斯中國控股有限公司)(incorporated in Hong Kong as a public limited company)(the “Issuer”) (ISIN: XS2314779427 Common Code: 231477942)(Stock Code: 40629)(the “Notes”) HONG KONG,…
Read More » -
Business Wire5 February 2026
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Oracle Corporation Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$ORCL #Oracle—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased…
Read More » -
Business Wire5 February 2026
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the BlackRock TCP Capital Corp. Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$TCPC #Banking—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased…
Read More » -
Business Wire5 February 2026
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
– Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals…
Read More » -
Business Wire5 February 2026
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$RARE #Health—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased…
Read More » -
Business Wire5 February 2026
Renesas Reports Financial Results for the Year Ended December 31, 2025
TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the year ended December 31,…
Read More » -
Business Wire5 February 2026
Notice Concerning the Difference between Renesas’ Financial Results for the Year Ended December 31, 2025, and Results in the Previous Period
TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE: 6723, “Renesas”), a premier supplier of advanced semiconductor solutions, today announced the difference between its…
Read More » -
Business Wire5 February 2026
Renesas Announces Consolidated Forecasts
TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE: 6723, “Renesas”), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts…
Read More » -
Business Wire5 February 2026
CDB Aviation Issues $500 Million Senior Unsecured Notes
Issuance Further Enhances Lessor’s Diversified Capital Structure DUBLIN–(BUSINESS WIRE)–#CDBAviation–CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial…
Read More »
